Leo International Precision Health bonus share allocation
Analysis based on 9 articles · First reported Aug 03, 2026 · Last updated Aug 03, 2026
The bonus share allocation increases the number of outstanding shares of Leo International Precision Health AG, potentially diluting existing shareholders but reflecting a capital restructuring from own funds. The market impact is likely minimal as it is a routine corporate action, with no change in the company's underlying value.
Leo International Precision Health AG, a German precision health company, executed a capital increase from the company's own funds, resolved at its Annual General Meeting on 12 June 2026 and entered in the Commercial Register on 28 July 2026. As part of this, the company allocated bonus shares to persons discharging managerial responsibilities and closely associated persons. Specifically, Mr Leo Wang, a member of the administrative or supervisory body, received 78,844,000 bonus shares, and PC Beteiligungsgesellschaft mbH, closely associated with Mr Phillip Campell, a member of the managing body, received 3,772,368 bonus shares. The transactions occurred on 28 July 2026 outside a trading venue, with prices and volumes not numerable. These allocations are part of the company's capital restructuring and do not involve cash consideration.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard